CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 4 Open-market sale Chief Financial Officer sold 141 shares at $23.51 ($3,315)
- 4 Open-market sale Chief Medical Officer sold 70 shares at $23.51 ($1,646)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 349 shares at $27.51 ($9,602)
- 4 Open-market sale Chief Financial Officer sold 358 shares at $25.07 ($8,975)
- 4 Exercise or conversion Chief Executive Officer acquired 35,229 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 70 shares at $24.35 ($1,705)
- 4 Open-market sale Chief Financial Officer sold 141 shares at $24.35 ($3,433)
- 4 Open-market sale Chief Operating Officer sold 145 shares at $24.35 ($3,531)
- 4 Shares withheld for taxes Chief Medical Officer gave up 345 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 360 shares at $29.68 ($10,685)
- 4 Open-market sale Chief Operating Officer sold 612 shares at $28.04 ($17,160)
- 3/A Insider 3/A
- 3/A Insider 3/A
Page 9 of 12 · 233 filings